Nedocromil Sodium (Akorn, Inc.)
Welcome to the PulseAid listing for the Nedocromil Sodium drug offered from Akorn, Inc.. This Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Akorn, Inc. |
NON-PROPRIETARY NAME: | Nedocromil Sodium |
SUBSTANCE NAME: | NEDOCROMIL SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC] |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-09-10 |
END MARKETING DATE: | 0000-00-00 |
Nedocromil Sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Nedocromil Sodium from Akorn, Inc. |
LABELER NAME: | Akorn, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/mL) |
START MARKETING DATE: | 2012-09-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17478-066_9496f818-72c7-400f-a6ee-77c851f0d320 |
PRODUCT NDC: | 17478-066 |
APPLICATION NUMBER: | ANDA090638 |
Other NEDOCROMIL SODIUM Pharmaceutical Manufacturers / Labelers: